SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-034230
Filing Date
2017-06-27
Accepted
2017-06-27 08:36:11
Documents
2
Group Members
SAIF IV GP CAPITAL LTD.SAIF IV GP, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v469618_sc13da.htm SC 13D/A 79788
2 EXHIBIT 7.01 v469618_ex7-01.htm EX-7.01 8185
  Complete submission text file 0001144204-17-034230.txt   89693
Mailing Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Subject) CIK: 0001084201 (see all company filings)

IRS No.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79318 | Film No.: 17931196
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address SAIF PARTNERS, 2 PACIFIC PL., STE. 2115 88 QUEENSWAY HONG KONG K3 00000
Business Address SAIF PARTNERS, 2 PACIFIC PL., STE. 2115 88 QUEENSWAY HONG KONG K3 00000 852-2918-2205
SAIF Partners IV L.P. (Filed by) CIK: 0001472789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A